SciELO - Scientific Electronic Library Online

 
vol.23 número2Características inmunofenotípicas del linfoma difuso de células grandes B y expresión de la proteína C-MYC: experiencia en un centro de EcuadorImportancia del acceso de los registros de cáncer de base poblacional a las estadísticas vitales: barreras identificadas en Colombia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Colombiana de Cancerología

versión impresa ISSN 0123-9015

Resumen

OSPINO, Rosalba et al. Updating the indications for the use of Intensity-Modulated Radiation Therapy in the Instituto Nacional de Cancerología - Colombia. Clinical protocol reported in the evidence. rev.colomb.cancerol. [online]. 2019, vol.23, n.2, pp.45-55. ISSN 0123-9015.  https://doi.org/10.35509/01239015.59.

Background:

Intensity-Modulated Radiation Therapy (IMRT) is an advanced technique which has been put into service in several clinical settings around the world; however, its proper use in Colombia requires to be revisited.

Aim:

To update an evidence-based clinical care protocol (CCP) that contains clinical recommendations for using IMRT in order to treat the most common oncological malignancies seen in the Radiotherapy Unit of the Instituto Nacional de Cancerología - Colombia.

Methods:

The elaboration of this CCP was undertaken by a multidisciplinary team who abided by a domestic CCP-development handbook. Briefly, a systematic search of literature was conducted; afterwards, relevant papers were selected and evaluated using appropriate appraisal tools; finally, evidence was summarized, contextualized, and used for generating the recommendations through a formal consensus approach (RAND/UCLA).

Results:

We established a handful of recommendations for using the IMRT technique in patients with any of the following types of cancer: prostate & penis, head & neck, skin, central nervous system, breast, soft tissue sarcoma, lung, gastrointestinal, and gynecologic, as well as oncologic emergencies.

Conclusions:

During the period 2014 - 2017, few evidence has emerged about the impact of IMRT on outcomes related to survival and quality of life; therefore, IMRT use still remains in selected patients.

Palabras clave : Clinical Protocols; Neoplasms; Radiotherapy, Inte39nsity-Modulated.

        · resumen en Español     · texto en Español     · Español ( pdf )